The COID concluded that the use of a fluoroquinolone in a child or adolescent may be justified in special circumstances, after careful assessment of the risks and benefits for the individual patient. Although there is no compelling evidence linking fluoroquinolones with sustained injury to developing joints in humans, the possibility that this may occur infrequently has not been excluded, Dr. Powell and his associates said.